Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder

Brain Pathology

Volumn 9, Issue 2, 1999, Pages 209-217

  Everall, I P ^a   Heaton, R K ^b   Marcotte, T D ^b   Ellis, R J ^c   McCutchan, J A ^d   Atkinson, J H ^b   Grant, I ^b   Mallory, M ^c   Masliah, E ^c,e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN;

ADULT; ARTICLE; ASTROCYTOSIS; CELL DENSITY; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; MALE; NERVE CELL LESION; NEUROPATHOLOGY; SCORING SYSTEM; SYNAPSE; VIRUS LOAD;

EID: 0032895217     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1999.tb00219.x     Document Type: Article

References (35)

1. AAN (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41: 778-785
2. Achim C, Wang R, Miners DK, Wiley CA (1994) Brain viral burden in HIV infection. J Neuropathol Exp Neurol 53: 284-294
3. An SF, Giometto B, Scaravilli F (1996) HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with the stage of disease. Ann Neurol 40: 611-617
4. Asare E, Dunn G, Glass J, McArthur J, Luthert P, Lantos P, Everall I (1996) Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Usefulness of spatial pattern analysis in clinicopathological studies. Am J Pathol 148: 31-38
5. Bennett BA, Rusyniak DE, Hollingsworth CK (1995) HIV-1 gp120 induced neurotoxicity to midbrain dopamine cultures. Brain Res 705: 168-176
6. Budka H, Wiley CA, Kleihues P, Artigas J, Ashbury AK, Cho E-S, Cornblath DR (1991) HIV-associated disease of the nervous system: Review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1: 143-152
7. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA (1990) HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248: 364-367
8. Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR, Grant I, HNRC Group (1997) Neurocognitive impairment is an independent risk factor for death in HIV infection. Arch Neurol 54: 416-424
9. Everall I, Gray F, Barnes H, Durigon M, Luthert PJ, Lantos PL (1992) Neuronal loss in symptom-free HIV infection. Lancet 340: 1413
10. Everall IP, DeTeresa R, Terry R, Masliah E (1997) Comparison of two quantiative methods for the evaluation of neuronal number in the frontal cortex in Alzheimer disease. J Neuropathol Exp Neurol 56: 1202-1206
11. Everall IP, Gray F, Masliah E (1998) Neuronal injury and apoptosis. In: The Neurology of AIDS, Gendelman HE, Lipton SA, Epstein L, Swindells S (eds.), pp. 261-274, International Thomson Publishing: New York
12. Everall IP, Hudson L, Al-Sarraj S, Honavar M, Lantos P, Kerwin R (1995) Decreased expression of AMPA receptor messenger RNA and protein in AIDS: a model for HIV-associated neurotoxicity. Nature Med 1: 1174-1178
13. Everall IP, Luthert PJ, Lantos PL (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 337: 1119-1121
14. Everall IP, Luthert PJ, Lantos PL (1993) Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psych 56: 481-486
15. Glass J, Fedor H, Wesselingh SL, McArthur JC (1995) Immunocytochemical quantification of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755-762
16. Grant I, Heaton RK, Atkinson JH, HNRC Group (1995) Neurocognitive disorder in HIV-1 infection. In: Current topics in microbiology and immunology. HIV and dementia, Oldstone MBA, Vitovic L (eds.), pp. 9-30, Springer-Verlag, Heidelberg
17. Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ, Wolfson T, Velin R, Marcotte TD, Hesselink JR, Jernigan TL, Cahndler J, Wallace M, Abramson I, HNRC Group (1995) The HNRC 500 - neuropsychology of HIV infection at different disease stages. J Int Neuropsych Soc 1: 231-251
18. Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, Godfrey HPD, Kirson DA, Grant I (1994) Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. Psychosomatic Med 56: 8-17
19. Johnson RT, Glass JD, McArthur JC, Cheesbro BW (1996) Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. Ann Neurol 39: 392-395
20. Magnuson DSK, Knudsen BE, Geiger JD, Brownstone RM, Nath A (1995) Human immunodefciency virus type 1 activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 37: 373-380
21. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA (1992) Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 32: 321-329
22. Masliah E, Ge N, Achim C, Hansen LA, Wiley CA (1992) Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol 51: 585-593
23. Masliah E, Ge N, Achim CL, Wiley CA (1994) Cytokine receptor localization in human central nervous system in vivo and in vitro: correlation with HIV infection. Brain Res 663: 1-6
24. Masliah E, Ge N, Achim CL, Wiley CA (1995) Differential vulnerability of calbindin-immunoreactive neurons in HIV encephalitis. J Neuropathol Exp Neurol 54: 350-357
25. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan A, Nelson JA, Atkinson H, Grant I, HNRC Group (1997) Dendritic injury is a pathological substrate for human immunodefficiency virus-related cognitive disorders. Ann Neurol 42: 963-972
26. McArthur JC, Grant I (1997) HIV neurocognitive disorders. In: Neurological and neuropsychiatric manifestations of HIV-1 infection, Gendelman HE, Lipton SA, Epstein L, Swindells S (eds.), Chapter 35, pp. 499-523, Chapman and Hall: New York
27. Mouton PR, Price DL, Walker LC (1997) Empirical assessment of synapse numbers in primate neocortex. J Neurosci Methods 75: 119-126
28. Nath A, Padua RA, Geiger JD (1995) HIV-1 coat protein gp120-induced increases in levels of intrasynaptosomal calcium. Brain Res 678: 200-206
29. Saito Y, Sharer L, Epstein LG, Michaels J, Mintz M, Louder M, Golding K, Cvetkovich TA, Blumberg BM (1994) Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44: 474-481
30. Saitoh T, Kang D, Mallory M, DeTeresa R, Masliah E (1997) Glial cells in Alzheimer's disease: Preferential effect of APOE risk on scattered microglia. Gerontology 43: 109-118
31. Subbiah P, Mouton P, Fedor H, McArthur JC, Glass JD (1996) Stereological analysis of cerebral atrophy in human immunodeficiency virus-associated dementia. J Neuropathol Exp Neurol 55: 1032-1037
32. Terry RD, DeTeresa R, Hansen LA (1987) Neocortical cell counts in normal human adult aging. Ann Neurol 21: 530-539
33. Toggas SM, Masliah E, Rockenstein EM, Mucke L (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367: 188-193
34. Wiley CA, Achim C (1994) HIV encephalitis is the pathologic correlate of dementia in AIDS. Ann Neurol 36: 673-676
35. Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry RD (1991) Neocortical damage during HIV infection. Ann Neurol 29: 651-657